Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1991 • 2,353 citations

The Influence of Finasteride on the Development of Prostate Cancer

2021 • 2,078 citations

Phases of Biomarker Development for Early Detection of Cancer

2001 • 1,572 citations

Purification of a Human Prostate Specific Antigen

2016 • 844 citations

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

1990 • 767 citations

Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer

1998 • 728 citations

Screening for Prostatic Carcinoma with Prostate Specific Antigen

1992 • 631 citations

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status

2000 • 528 citations

TWO CONSECUTIVE SETS OF TRANSRECTAL ULTRASOUND GUIDED SEXTANT BIOPSIES OF THE PROSTATE FOR THE DETECTION OF PROSTATE CANCER

1998 • 415 citations

Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled Trial

1999 • 343 citations

Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific Antigen

2003 • 328 citations

Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

1994 • 318 citations

Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.

1980 • 278 citations

Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging

1985 • 241 citations

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study

1996 • 180 citations

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

2002 • 173 citations

Adenocarcinoma of the Prostate: Results of Routine Urological Screening

1984 • 163 citations

Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markers

1986 • 120 citations

Tumour Markers in Prostatic Carcinoma. A Comparison of Prostate‐specific Antigen with Acid Phosphatase

1987 • 101 citations

Multiple Marker Evaluation in Human Prostate Cancer With the Use of Tissue-Specific Antigens<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

1982 • 96 citations

Prostate Cancer Incidence and Mortality in the United States and the United Kingdom

1998 • 89 citations

Measurement of prostate-specific antigen by radioimmunoassay.

1984 • 80 citations

Serum Prostatic Antigen Measurement in Localized Prostatic Cancer: Correlation with Clinical Course

1982 • 64 citations

A Double-Blind Study of Trimethoprim-Sulfamethoxazole Prophylaxis in Patients Having Transrectal Needle Biopsy of the Prostate

1979 • 62 citations

The epidemiology of prostate cancer part I: descriptive epidemiology.

1998 • 60 citations

Ultrasound-guided prostate biopsy Biopty gun superior to aspiration

1988 • 59 citations

The Prostate Cancer Prevention Trial: design, status, and promise

2003 • 35 citations

Biomarker-based methods for determining noncompliance in a prevention trial

2002 • 12 citations